Pimentel, F. F. (2021) “SYNERGISTIC MECHANISMS OF ACTION: COMPARISON OF ADCC AND SIGNALING PATHWAYS INHIBITION BY TRASTUZUMAB BIOSIMILAR OR ORIGINATOR TRASTUZUMAB IN COMBINATION WITH PERTUZUMAB IN HER2+ BREAST CANCER CELL LINES”, Mastology. Rio de Janeiro, 31, p. 9. doi: 10.29289/259453942021v31s2009.